Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
GLP-1 medications slow down gastric emptying, leading to fermentation of food in the stomach and the production of hydrogen sulfide gas, which can result in sulfur burps
Avoiding compounded alternatives assures every prescription meets rigorous safety and efficacy standards set by clinical trials
Older adults may be more sensitive to the drugs side effects, such as stomach bleeding, heart problems, and kidney issues
An earlier study in the New England Journal of Medicine (Wang et al., 2011) made similar observations in relation to dietary choline and phosphatidylcholine
Also, both systolic and diastolic dysfunction stemming from the interplay between atherosclerotic coronary disease and diabetic cardiomyopathy are associated with the underlying pathophysiology of HF in patients with T2DM [45, 46]
